Amicar and Ventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Ventricular tachycardia is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Digoxin, and have Anaesthesia.

The phase IV clinical study analyzes which people have Ventricular tachycardia when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,290 drugs and 2,096 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.

On Jul, 15, 2026

1,317 people reported to have side effects when taking Amicar.
Among them, 14 people (1.06%) have Ventricular tachycardia.

Could Amicar cause Ventricular tachycardia?

Among these 14 people:

How long have people been on Amicar when they have Ventricular tachycardia? *

What is the gender of people who have Ventricular tachycardia when taking Amicar? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Ventricular tachycardia when taking Amicar? *

What are other drugs people take besides Amicar? *

What are other side effects people have besides Ventricular tachycardia? *

Hypotension (abnormally low blood pressure): 10 people, 71.43%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 57.14%
Fever: 7 people, 50.00%
Weakness: 6 people, 42.86%
Nosebleed (bleeding from nose): 6 people, 42.86%
Melaena (the passage of black, tarry stools): 6 people, 42.86%
Dyspnea (difficult or laboured breathing): 6 people, 42.86%
Acute Kidney Failure: 6 people, 42.86%
Enterobacter Pneumonia (lung inflammation caused by bacteria of the family enterobacteriaceae): 5 people, 35.71%
Enlarged Heart: 5 people, 35.71%

What are the existing conditions these people have? *

Respiratory Disorder (respiratory disease): 5 people, 35.71%
Nausea (feeling of having an urge to vomit): 5 people, 35.71%
Anaesthesia: 5 people, 35.71%
Pain In Extremity: 3 people, 21.43%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 7.14%
Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 7.14%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Amicar and have Ventricular tachycardia?

- Check whether Ventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amicar:

Amicar (1,323 reports)

Browse all side effects of Amicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular tachycardia:

Ventricular tachycardia (1,290 drugs)

Browse all the conditions that are associated with Ventricular tachycardia:

Ventricular tachycardia (2,096 conditions)

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.